Oscar HealthOSCR.NValuation Analysis

As of Oct 16, 2026, Oscar Health (OSCR.N) trades at a P/E of 17.90x, P/B of 4.80x, P/S of 0.64x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 13th percentile over the trailing 10Y window (vs. 13th percentile over 3Y); P/B sits at the 91st percentile over the trailing 10Y window (vs. 83rd percentile over 3Y); P/S sits at the 72nd percentile over the trailing 10Y window (vs. 85th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 56th percentile within its industry and the 46th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
Notably, P/E and P/B aren't telling quite the same story, 77.6 points apart — worth checking the full percentile matrix on this page for the complete picture. The P/E percentile sits lower across the market than within its own industry — relatively cheaper next to the market as a whole. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Oscar Health operates in the Finance, Insurance, And Real Estate sector. Data refreshes weekly and is for reference only, not investment advice.